Susan Morrison Biography and Net Worth

Susan Morrison has served as our Chief Administrative Officer since September 2013 and as an Executive Vice President since December 2017, and is responsible for the Company’s investor relations, corporate communications, project management, human resources and facilities functions. From April 2013 until September 2013, she served as our Vice President, Human Resources, Corporate and Investor Relations. Ms. Morrison served as our Director, Corporate and Investor Relations, from January 2009 to March 2013, and was our Director, Corporate Services from November 2007 to December 2008. Prior to joining our Company, Ms. Morrison held various positions in Corporate and Investor Relations at Biosite from August 2003 through November 2007. Ms. Morrison holds a BA in Public Relations from Western Michigan University.

What is Susan Morrison's net worth?: The estimated net worth of Susan Morrison is at least $330.56 thousand as of August 28th, 2020. Ms. Morrison owns 13,778 shares of Tandem Diabetes Care stock worth more than $330,562 as of March 26th. This net worth evaluation does not reflect any other investments that Ms. Morrison may own. Learn More about Susan Morrison's net worth.
How do I contact Susan Morrison?: The corporate mailing address for Ms. Morrison and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Susan Morrison's contact information.
Has Susan Morrison been buying or selling shares of Tandem Diabetes Care?: Susan Morrison has not been actively trading shares of Tandem Diabetes Care during the last ninety days. Most recently, Susan Morrison sold 34,624 shares of the business's stock in a transaction on Tuesday, November 16th. The shares were sold at an average price of $142.21, for a transaction totalling $4,923,879.04. Learn More on Susan Morrison's trading history.
Who are Tandem Diabetes Care's active insiders?: Tandem Diabetes Care's insider roster includes Dick Allen (Director), David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), Shannon Hansen (Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary), Jean-Claude Kyrillos (Executive Vice President and Chief Operating Officer), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Mark Novara (Executive Vice President and Chief Commercial Officer), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.
Are insiders buying or selling shares of Tandem Diabetes Care?: In the last twelve months, Tandem Diabetes Care insiders bought shares 2 times. They purchased a total of 23,720 shares worth more than $251,710.80. In the last twelve months, insiders at the medical device company sold shares 2 times. They sold a total of 189 shares worth more than $4,355.97. The most recent insider tranaction occured on March, 17th when EVP Mark David Novara sold 187 shares worth more than $4,310.35. Insiders at Tandem Diabetes Care own 1.9% of the company. Learn More about insider trades at Tandem Diabetes Care.
Information on this page was last updated on 3/17/2026.

Susan Morrison Insider Trading History at Tandem Diabetes Care

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/16/2021	Sell	34,624	$142.21	$4,923,879.04
11/3/2021	Sell	5,376	$142.00	$763,392.00
10/13/2021	Sell	10,048	$132.01	$1,326,436.48
9/1/2020	Sell	20,000	$114.00	$2,280,000.00	13,778
8/28/2020	Sell	7,522	$114.00	$857,508.00	13,778
7/31/2020	Sell	50,000	$108.58	$5,429,000.00	36,256
3/1/2019	Sell	60,000	$67.79	$4,067,400.00	53,745

Susan Morrison Buying and Selling Activity at Tandem Diabetes Care

Tandem Diabetes Care Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $23.39

$23.49

$24.30

50 Day Range

MA: $21.66

$18.52

$28.26

2 Week Range

Now: $23.39

$9.98

$29.65

Volume

392,385 shs

Average Volume

1,988,074 shs

Market Capitalization

$1.60 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.63